Quimpharma has completed the divestiture of a product portfolio to Megalabs
April 2026 — Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Quimpharma is a Mexican pharmaceutical company focused on the development, manufacture and distribution of prescription, over-the-counter (OTC), food supplement and dermocosmetic products. With over 22 years of history, the company has established a strong position in the Mexican market, supported by a robust R&D division and a portfolio of more than 40 products across key therapeutic categories. The company operates a manufacturing facility with liquid and solid production lines, a distribution center and corporate offices in Mexico City, enabling nationwide reach and consistent product availability.
Megalabs México, through Italmex, is part of Megalabs, a Uruguay-based pharmaceutical group with a strong presence across Latin America. The company develops and commercializes innovative, high-quality pharmaceutical products, dermocosmetics and nutritional supplements across multiple therapeutic areas, working closely with healthcare professionals to support patients’ health and wellbeing throughout Mexico and the region.
Our role in the transaction
Oaklins’ team in Mexico acted as the exclusive sell-side advisor to Quimpharma in the divestiture of a product portfolio to Megalabs. This transaction highlights Oaklins’ expertise in the healthcare sector and reinforces its strong track record advising mid-market companies through complex, cross-border processes.
Talk to the deal team
Related deals
Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn moreitemedical has been acquired by Halma
itemedical, a Netherlands-based provider of digital platforms that integrate real-time patient data and alarms from a wide range of medical devices to support clinical decision-making and workflow efficiency in hospitals, has been acquired by Halma plc, a global group of life-saving technology companies. The acquisition represents a milestone in itemedical’s development and provides a platform for its next phase of growth. By joining Halma’s healthcare sector as a business unit of Halma subsidiary Static Systems Group (SSG), itemedical will strengthen its position as a provider of digital hospital workflow solutions, benefiting from access to a global network of technology businesses, resources to accelerate innovation and opportunities to expand its international footprint.
Learn moreIndigo Capital has acquired a minority stake in Vivason
Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.
Learn more